Summary of Product Characteristics
last updated on the eMC:
11/09/2007
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 11/09/2007 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
| Date of revision of text on the SPC: 11/2006 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Section 7 (Marketing Authorisation Holder): change to sanofi-aventis.
|
|
Updated on 08/08/2005 and displayed until 11/09/2007
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 27/09/2004 and displayed until 08/08/2005
|
Reasons for adding or updating:
|
-
Change to section 5.1 - Pharmacodynamic Properties
|
|
Updated on 23/08/2002 and displayed until 27/09/2004
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
|